tiprankstipranks
Trending News
More News >
Sartorius Stedim Biotech (GB:0RG8)
LSE:0RG8
UK Market

Sartorius Stedim Biotech (0RG8) Ratios

Compare
1 Followers

Sartorius Stedim Biotech Ratios

GB:0RG8's free cash flow for Q1 2025 was €0.48. For the 2025 fiscal year, GB:0RG8's free cash flow was decreased by € and operating cash flow was €0.24. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
1.85 1.51 1.61 1.40 1.54
Quick Ratio
1.14 0.57 0.62 0.65 0.71
Cash Ratio
0.73 0.12 0.10 0.22 0.11
Solvency Ratio
0.12 0.11 0.41 0.25 0.28
Operating Cash Flow Ratio
0.91 0.67 0.59 0.67 0.73
Short-Term Operating Cash Flow Coverage
12.75 10.91 136.07 27.29 31.79
Net Current Asset Value
€ -2.52B€ -3.65B€ -880.00M€ -762.24M€ -711.20M
Leverage Ratios
Debt-to-Assets Ratio
0.35 0.48 0.22 0.16 0.19
Debt-to-Equity Ratio
0.74 1.40 0.46 0.38 0.40
Debt-to-Capital Ratio
0.42 0.58 0.32 0.27 0.29
Long-Term Debt-to-Capital Ratio
0.40 0.57 0.29 0.24 0.26
Financial Leverage Ratio
2.09 2.93 2.07 2.39 2.10
Debt Service Coverage Ratio
2.92 3.82 47.73 16.14 25.17
Interest Coverage Ratio
2.72 4.14 53.51 65.71 69.19
Debt to Market Cap
0.14 0.16 0.04 0.01 0.02
Interest Debt Per Share
31.84 41.22 12.52 6.90 6.44
Net Debt to EBITDA
3.05 4.72 0.76 0.49 0.84
Profitability Margins
Gross Profit Margin
43.89%44.44%52.52%53.79%52.50%
EBIT Margin
14.75%18.70%32.90%23.22%24.48%
EBITDA Margin
25.55%27.23%38.74%28.12%32.66%
Operating Profit Margin
15.61%17.46%28.49%23.67%24.70%
Pretax Profit Margin
9.00%14.45%32.36%22.40%25.27%
Net Profit Margin
7.15%11.16%25.08%14.35%17.59%
Continuous Operations Profit Margin
7.23%11.24%25.19%14.35%17.73%
Net Income Per EBT
79.43%77.21%77.50%64.08%69.60%
EBT Per EBIT
57.66%82.79%113.59%94.65%102.29%
Return on Assets (ROA)
2.46%4.00%17.30%10.49%10.94%
Return on Equity (ROE)
5.19%11.74%35.77%25.03%23.01%
Return on Capital Employed (ROCE)
6.08%7.12%24.70%23.45%18.86%
Return on Invested Capital (ROIC)
4.82%5.48%19.11%14.82%13.95%
Return on Tangible Assets
5.37%9.80%28.70%16.94%21.53%
Earnings Yield
1.04%1.40%3.14%0.93%1.25%
Efficiency Ratios
Receivables Turnover
10.70 9.45 8.34 7.77 7.24
Payables Turnover
5.06 5.97 6.59 5.31 5.19
Inventory Turnover
2.35 1.75 1.62 1.70 1.92
Fixed Asset Turnover
1.48 1.70 2.70 3.11 2.97
Asset Turnover
0.34 0.36 0.69 0.73 0.62
Working Capital Turnover Ratio
3.53 4.99 6.63 7.95 7.43
Cash Conversion Cycle
117.53 186.30 213.96 192.47 170.15
Days of Sales Outstanding
34.10 38.62 43.75 47.00 50.44
Days of Inventory Outstanding
155.59 208.87 225.58 214.23 189.99
Days of Payables Outstanding
72.16 61.19 55.36 68.76 70.29
Operating Cycle
189.70 247.49 269.32 261.23 240.43
Cash Flow Ratios
Operating Cash Flow Per Share
9.04 6.83 6.64 7.55 4.52
Free Cash Flow Per Share
6.00 1.69 1.97 4.04 2.80
CapEx Per Share
3.04 5.14 4.67 3.51 1.73
Free Cash Flow to Operating Cash Flow
0.66 0.25 0.30 0.53 0.62
Dividend Paid and CapEx Coverage Ratio
2.42 1.04 1.12 1.80 2.19
Capital Expenditure Coverage Ratio
2.97 1.33 1.42 2.15 2.62
Operating Cash Flow Coverage Ratio
0.30 0.17 0.54 1.11 0.71
Operating Cash Flow to Sales Ratio
0.31 0.23 0.18 0.24 0.22
Free Cash Flow Yield
2.96%0.71%0.65%0.84%0.96%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
96.42 71.27 31.82 107.30 79.90
Price-to-Sales (P/S) Ratio
6.89 7.95 7.98 15.40 14.05
Price-to-Book (P/B) Ratio
4.96 8.37 11.38 26.85 18.38
Price-to-Free Cash Flow (P/FCF) Ratio
33.76 141.40 153.44 119.54 104.17
Price-to-Operating Cash Flow Ratio
22.40 35.05 45.53 63.89 64.39
Price-to-Earnings Growth (PEG) Ratio
5.78 -1.10 0.29 4.54 1.85
Price-to-Fair Value
4.96 8.37 11.38 26.85 18.38
Enterprise Value Multiple
30.03 33.93 21.36 55.26 43.88
Enterprise Value
21.93B 25.64B 28.91B 44.87B 27.37B
EV to EBITDA
30.03 33.93 21.36 55.26 43.88
EV to Sales
7.67 9.24 8.28 15.54 14.33
EV to Free Cash Flow
37.57 164.24 159.10 120.62 106.21
EV to Operating Cash Flow
24.93 40.71 47.21 64.47 65.65
Tangible Book Value Per Share
-5.07 -20.78 5.43 2.47 -0.28
Shareholders’ Equity Per Share
40.84 28.63 26.58 17.96 15.84
Tax and Other Ratios
Effective Tax Rate
0.20 0.22 0.22 0.36 0.25
Revenue Per Share
29.38 30.12 37.90 31.32 20.72
Net Income Per Share
2.10 3.36 9.51 4.50 3.64
Tax Burden
0.79 0.77 0.78 0.64 0.70
Interest Burden
0.61 0.77 0.98 0.96 1.03
Research & Development to Revenue
0.05 0.05 0.04 0.04 0.04
SG&A to Revenue
0.06 0.06 0.04 0.04 0.05
Stock-Based Compensation to Revenue
0.00 0.00 0.00 <0.01 <0.01
Income Quality
3.83 2.03 0.54 1.08 0.86
Currency in EUR
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis